Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

SPIKE FLOW endocardial pacing lead safety and performance study

Official title: A Prospective Multi-center Single Arm Study Evaluating the Safety and Performance of the SPIKE FLOW Endocardial Lead

Run by FIAB SpA · NCT07820072 · Data updated 2026-11-12

This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment131 (estimated)
SponsorFIAB SpA
Industry-sponsored
Locations3 sites (Acquaviva delle Fonti, Bari and 2 other locations)
StatusRecruiting
StartedAugust 7, 2026
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedOctober 20, 2026
Trial IDNCT07820072 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older undergoing a procedure requiring temporary cardiac pacing or evaluated for transient vs permanent bradycardia, who consent to participate.

Probably not a fit

Patients already implanted with permanent pacing or defibrillator, or those in cardiogenic shock or with certain exclusion conditions, may not benefit from this device in this setting.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, non-randomized, single-arm study evaluates the safety and performance of the SPIKE FLOW temporary endocardial pacing leads across multiple centers in Italy. Primary endpoints look at safety as freedom from Serious Adverse Events and pacing performance via mean capture threshold. Secondary endpoints include freedom from Adverse Events, impedance, and sensed R-wave amplitude. Approximately 131 adults undergoing procedures requiring temporary pacing will be enrolled over about one year with follow-up visits around lead insertion and removal.

Why it matters

Potential benefit: If successful, the SPIKE FLOW leads could provide reliable temporary cardiac pacing with predictable performance during short-term clinical needs.

How similar studies have gone: Prior studies of temporary endocardial leads have demonstrated feasibility and safety in similar contexts, but this specific SPIKE FLOW device is being evaluated in a non-randomized, single-arm design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject undergoing a surgical or an interventional procedure, requiring temporary cardiac pacing per investigator's medical judgment or subjects with bradycardia who are under evaluation to determine if the cause is transient or permanent;
* Subject is at least 18 years of age;
* Subject provides written informed consent to the study.

Exclusion Criteria:

* Subject has a co-existing temporary pacing or an implanted active permanent pacemaker or a cardiac defibrillator;
* Subject in cardiogenic shock;
* Subject is currently in atrial fibrillation;
* Subject is pregnant or breastfeeding;
* Subject had a stroke within 6 months prior to enrollment;
* Subject has renal insufficiency with creatinine \>2 mg/dl;
* Subject with known bleeding diathesis;
* Subject with a history of deep vein thrombosis or pulmonary embolism within 6 months;
* Subject with known tricuspid valve disease that may impede catheter advancement to and withdrawal from the right ventricle;
* Subject with known intracardiac thrombus or vegetation on echocardiography;
* Subject with significant neck abnormalities such that placement of a right and/or left internal jugular vein line would be difficult;
* Subject has an active systemic infection or local infection at or around the insertion site;
* Subject is involved in another clinical study that could influence the safety or outcome measures of this study.

Where it's running

  • Ospedale del Cuore 'G. Pasquinucci' Fondazione Toscana 'Gabriele Monasterio'
    Massa, Massa-Carrara, Italy
    Recruiting
  • Azienda Ospedaliero Universitaria Pisana
    Pisa, Pisa, Italy
    Recruiting
  • Ospedale Generale Regionale "F. Miulli"
    Acquaviva delle Fonti, Bari, Italy
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.